DX Group
DX
$10.92
-1.18%
Dynex Capital, Inc. is an internally managed mortgage real estate investment trust (REIT) that invests primarily in agency-guaranteed residential and commercial mortgage-backed securities (RMBS and CMBS), funding its portfolio with repurchase agreements and equity capital. The company occupies a distinct niche within the mortgage REIT universe: it is a small, highly leveraged, spread-harvesting vehicle with only 28 employees, meaning its returns are driven almost entirely by asset selection, hedging discipline, and financing costs rather than operating scale. The current investor narrative is dominated by the tension between a double-digit dividend yield and a sharply deteriorating share price, as book-value erosion, compressed net interest spreads, and a series of equity raises that expanded the share count have weighed heavily on sentiment. With the stock down more than 20% year-to-date and trading at a steep discount to book value, the debate centers on whether the current dividend is sustainable and whether the discount represents a genuine value opportunity or a warning of further NAV deterioration.…
DX
DX Group
$10.92
Investment Opinion: Should I buy DX Today?
Rating: Hold. DX offers a 14.18% dividend yield and trades at a 29% discount to book value, but the accelerating downtrend and dividend sustainability concerns warrant caution. The analyst consensus is 'buy' with an average target of $13.75 (25.8% upside), yet the stock's -22.37% YTD decline and proximity to its 52-week low suggest the market is pricing in further deterioration.
Supporting evidence: 1) Valuation: PB of 0.71x versus sector 0.8x-1.0x, near the low end of its historical range. 2) Revenue growth: Q2 2026 revenue of $302.75 million, up 170.9% YoY, but driven by share count doubling. 3) Profitability: Q2 2026 net margin of 59.7%, but trailing EPS of $0.18 is volatile. 4) Cash flow: FCF TTM of $236.58 million, but dividends exceed operating cash flow. 5) Analyst targets: Average $13.75 implies 25.8% upside, but the wide range ($12-$15) signals uncertainty.
Risks: A dividend cut would likely trigger further selling, and continued book value erosion could widen the discount. The rating would upgrade to Buy if the stock stabilizes above $11.50 and the dividend is covered by cash flow, or downgrade to Sell if the dividend is cut or book value declines below $10. Valuation verdict: Fairly valued to slightly undervalued relative to book, but the market is pricing in significant risk.
Sign up to view all
DX 12-Month Price Forecast
DX presents a high-risk, high-reward opportunity with a 14.18% yield and a 29% discount to book value, but the accelerating downtrend and dividend sustainability concerns keep the stance neutral. The base case (50% probability) sees the stock recovering toward $12-$13.75 as spreads stabilize, while the bear case (25%) targets the 52-week low of $10.36. An upgrade to bullish would require evidence of dividend coverage improvement and a break above $11.50-$12.00 resistance; a downgrade to bearish would follow a dividend cut or book value decline below $10.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on DX Group's 12-month outlook, with a consensus price target around $12.60 and implied upside of +15.4% versus the current price.
Average Target
$12.60
0 analysts
Implied Upside
+15.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$12 - $15
Analyst target range
Five analysts cover DX, with a consensus recommendation of "buy" (mean rating of 1.83 on a 1-to-5 scale where lower is more bullish) and an average target price of $13.75. Against the current price of $10.93, that implies upside of approximately +25.8%, a notably bullish signal for a stock in a severe downtrend, and the consensus leans clearly positive with no sell ratings evident in the coverage. The average forward EPS estimate of $1.68 (range $1.42 to $1.92) and revenue estimate of $616.03 million underpin the constructive stance, though the gap between the bullish consensus and the -17.20% one-year price performance highlights a significant disconnect between analyst expectations and market pricing.
The target range of $12.00 to $15.00 is moderately wide, spanning roughly 25% around the $13.75 midpoint, which signals meaningful uncertainty about book value and dividend sustainability. The high target of $15.00 would require a re-rating toward parity with book value and stabilization of net interest spreads, while the low target of $12.00 still implies about +9.8% upside and likely assumes continued book-value erosion but no dividend cut. Institutional ratings show a stable pattern rather than fresh momentum: Jones Trading has reiterated Buy repeatedly (most recently July 21, 2026), Keefe Bruyette & Woods has maintained Outperform, and UBS has stayed Neutral since April 2026, indicating analysts are holding their views rather than upgrading into the decline. The persistence of bullish ratings despite a -22.37% YTD move suggests either genuine conviction in mean reversion or lagging revisions, and investors should weigh the wide target spread and lack of recent upgrades as evidence that conviction is not strengthening.
Bulls vs Bears: DX Investment Factors
The bear case currently has stronger evidence: DX is in a severe, accelerating downtrend with a -22.37% YTD decline, trading just above its 52-week low, and the dividend appears stretched with a 77.3% payout ratio and dividends exceeding operating cash flow. However, the bull case is not without merit, as the stock trades at a 29% discount to book value and analysts see 25.8% upside. The single most important tension is whether the dividend is sustainable; a cut would likely trigger further selling, while maintenance could catalyze a re-rating toward book value. Resolution hinges on net interest spread stabilization and repo financing conditions.
Bullish
- Deep discount to book value: DX trades at a PB ratio of 0.71x, roughly a 29% discount to book value, which is near the low end of its historical 0.68x-0.94x range. For an agency MBS REIT with government-guaranteed collateral, this discount provides a margin of safety if spreads stabilize.
- Analyst consensus sees 25.8% upside: Five analysts rate DX a 'buy' with a mean rating of 1.83 and an average target price of $13.75, implying 25.8% upside from $10.93. The low target of $12.00 still offers 9.8% upside, suggesting even the bearish analyst sees limited downside.
- Double-digit dividend yield: DX offers a 14.18% dividend yield, well above the mortgage REIT sector's typical 9-11% range. While the payout ratio of 77.3% raises sustainability questions, the yield provides substantial income while waiting for a recovery.
- Positive operating cash flow and profitability: Despite earnings volatility, DX generated $236.58 million in trailing free cash flow and $84.15 million in quarterly operating cash flow. Q2 2026 net income was $180.79 million with a 59.7% net margin, showing the portfolio can produce strong returns when spreads cooperate.
Bearish
- Severe and accelerating downtrend: DX is down 22.37% YTD, 18.00% over three months, and 10.12% in the past month, with the stock at $10.93 just 5.5% above its 52-week low of $10.36. The falling-knife pattern and relative strength of -32.73% versus SPY over one year indicate persistent selling pressure.
- Dividend coverage is questionable: The 14.18% yield comes with a 77.3% payout ratio, and Q2 2026 dividends paid of $113.37 million exceeded operating cash flow of $84.15 million. This raises the risk of a dividend cut if portfolio cash flows deteriorate further.
- Extreme leverage leaves little cushion: Debt-to-equity is 5.65x and total debt to capitalization is 87.7%, typical for a mortgage REIT but risky if repo financing costs rise or haircuts increase. A cash ratio near zero and current ratio of 0 means liquidity depends entirely on repo rollover capacity.
- Earnings are highly volatile and mark-driven: Net income swung from -$80.36 million in Q1 2026 to +$180.79 million in Q2 2026, with EPS ranging from -$0.41 to $0.80. The trailing EPS of $0.18 versus forward EPS of $1.68 highlights how dependent reported earnings are on rate-driven unrealized marks.
DX Technical Analysis
DX is locked in a sustained downtrend, with the 1-year price change of -17.20% and a 6-month decline of -19.69% confirming persistent negative momentum rather than a temporary dip. At $10.93, the stock sits at just 13.3% of its 52-week range of $10.36 to $14.93, meaning it is trading near the very bottom of its annual band and only about 5.5% above the 52-week low. This positioning signals a falling-knife profile rather than a value entry point, as buyers have repeatedly failed to defend higher levels and the stock has made a sequence of lower highs and lower lows throughout the period.
Short-term momentum is decisively negative and accelerating: the 1-month change of -10.12% and 3-month change of -18.00% show that the pace of decline has steepened rather than stabilized, with the bulk of the damage occurring since mid-September when the stock fell from roughly $12.90 to the $10.50-$11.00 zone. This is a clear divergence from the broader market, evidenced by relative strength of -11.34% versus SPY over one month and -32.73% over one year, indicating the weakness is idiosyncratic to DX rather than macro-driven. Volume of approximately 7.47 million shares alongside a short ratio of 2.64 suggests active distribution and moderate short interest, reinforcing that sellers remain in control and rallies are likely being used to exit positions.
Key technical levels are well defined: the 52-week low of $10.36 is the critical support zone, and a breakdown below it would likely trigger momentum-driven selling and open the door to new lows, while the 52-week high of $14.93 represents distant resistance that would require a trend reversal to challenge. The beta of 0.965 indicates the stock moves roughly in line with the broader market, so the -17.20% one-year decline is not explained by market volatility but by company-specific factors, which matters for position sizing since the risk here is concentrated in credit and spread dynamics rather than broad beta exposure. The maximum drawdown of -28.29% underscores the severity of the current cycle and argues for tight risk controls until the price can reclaim even near-term resistance around the $11.50-$12.00 area.
Beta
0.96
0.96x market volatility
Max Drawdown
-28.4%
Largest decline past year
52-Week Range
$10-$15
Price range past year
Annual Return
-17.5%
Cumulative gain past year
| Period | DX Return | S&P 500 |
|---|---|---|
| 1m | -6.9% | -1.0% |
| 3m | -13.3% | +2.9% |
| 6m | -20.6% | +6.5% |
| 1y | -17.5% | +13.1% |
| ytd | -22.4% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DX Fundamental Analysis
Revenue has grown dramatically but unevenly: Q2 2026 revenue of $302.75 million rose 170.9% year-over-year versus $111.75 million in Q2 2025, yet the trajectory is highly volatile, with Q1 2026 at $257.39 million, Q4 2025 at $177.04 million, and Q3 2025 at $149.68 million. This growth is largely a function of balance-sheet expansion rather than organic spread improvement, as shares outstanding ballooned from roughly 113.2 million in Q2 2025 to 222.2 million in Q2 2026, meaning per-share economics have not kept pace with headline revenue. For a mortgage REIT, the relevant takeaway is that asset growth is being funded by equity issuance and heavy repo leverage, so the investment case hinges on whether incremental capital earns an adequate spread rather than on top-line expansion itself.
Profitability is extremely lumpy and mark-to-market driven: Q2 2026 net income was $180.79 million with a net margin of 59.7% and EPS of $0.80, a sharp swing from Q1 2026's net loss of -$80.36 million (EPS -$0.41) and Q2 2025's loss of -$13.61 million (EPS -$0.14). Gross margin of 30.98% in Q2 2026 reflects the interest expense burden of $208.97 million against $302.75 million of interest income, while the reported 100% gross margin in prior quarters is an artifact of REIT accounting rather than true operating profitability. The pattern of alternating large gains and losses is characteristic of agency MBS portfolios marked through the income statement, and the trailing EPS of $0.18 against a forward estimate of $1.68 highlights how dependent reported earnings are on rate-driven unrealized marks.
Financial health is defined by extreme leverage: debt-to-equity stands at 5.65x, total debt to capitalization is 87.7%, and the equity multiplier is 8.32x, all typical for a mortgage REIT but leaving little cushion for adverse spread moves. Free cash flow TTM of $236.58 million and quarterly operating cash flow of $84.15 million are positive, but the dividend paid of $113.37 million in Q2 2026 exceeded operating cash flow, and the payout ratio of 77.3% against a 14.18% dividend yield means the distribution is being supported by portfolio cash flows and capital markets access rather than fully covered by earnings. ROE of 12.96% and ROA of 2.31% look respectable in isolation, but with a cash ratio near zero and current ratio reported at 0, liquidity depends entirely on repo rollover capacity, making the company structurally dependent on external financing.
Quarterly Revenue
$302751000.0B
2026-06
Revenue YoY Growth
+170.9%
YoY Comparison
Gross Margin
31.0%
Latest Quarter
Free Cash Flow
$236576000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DX Overvalued?
Because net income is positive (trailing EPS of $0.18), the PE ratio is the appropriate primary metric, and DX trades at a trailing PE of 5.63x against a forward PE of 7.10x. The unusual pattern of a forward multiple exceeding the trailing multiple implies the market expects earnings to normalize lower from the mark-driven Q2 2026 spike, consistent with the wide gap between trailing EPS of $0.18 and the forward estimate of $1.68, which reflects the volatility of GAAP earnings for this REIT rather than a clean growth signal. For mortgage REITs, price-to-book is arguably more informative, and at a PB of 0.71x the stock is trading at a roughly 29% discount to book value.
Relative to the mortgage REIT sector, DX's 0.71x price-to-book sits at the low end of the typical 0.8x-1.0x range for agency-focused peers, implying a discount of roughly 15-25% versus the group, while its 5.63x trailing PE and 3.26x PS are difficult to benchmark directly because sector earnings are similarly distorted by marks. The discount appears justified by the company's aggressive 5.65x leverage, a dividend yield of 14.18% that is well above the sector's typical 9-11% range and signals market skepticism about sustainability, and a payout ratio of 77.3% that leaves limited coverage. The PEG ratio of 0.085 is not meaningful here given the instability of the earnings base and should not be read as a value signal.
Historically, DX has traded in a price-to-book band of roughly 0.68x to 0.94x over the past several years, with the current 0.71x near the bottom of that range and well below the 0.92x seen as recently as Q2 2026. The stock's PS ratio of 3.26x compares with historical readings of 9.62x in Q2 2026 and 12.35x in Q4 2025, though those figures are distorted by the rapid expansion of the revenue base, and the price-to-free-cash-flow ratio of 14.39x versus 34.62x in Q2 2026 shows how much the market has de-rated the cash flow stream. Trading near the low end of its own historical valuation band suggests the market is pricing in book-value erosion and dividend risk rather than optimism, which could represent value if spreads stabilize but reflects genuine fundamental deterioration if they do not.
PE
5.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 1x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. DX's debt-to-equity of 5.65x and total debt to capitalization of 87.7% leave little cushion for adverse spread moves, and the cash ratio near zero means liquidity depends entirely on repo rollover. The dividend payout ratio of 77.3% against a 14.18% yield, with Q2 2026 dividends of $113.37 million exceeding operating cash flow of $84.15 million, raises the risk of a cut if portfolio cash flows weaken. Additionally, earnings are highly volatile, with net income swinging from -$80.36 million in Q1 2026 to +$180.79 million in Q2 2026, driven by mark-to-market adjustments on agency MBS.
Market and competitive risks include valuation compression and sector rotation. DX trades at a PB of 0.71x, a discount to the sector's 0.8x-1.0x range, but this discount could widen if book value erodes further. The stock's beta of 0.965 indicates market-like volatility, but its -17.20% one-year decline versus SPY's +15.53% shows idiosyncratic weakness. With no recent news, the risk is that continued spread compression and prepayment risk could force another equity raise, diluting shareholders further. The small employee base of 28 means the company is highly dependent on a few key decision-makers.
Worst-case scenario: a combination of rising repo financing costs, widening mortgage spreads, and a dividend cut could drive the stock below its 52-week low of $10.36. From the current $10.93, that represents a decline of about 5.2%, but if book value erodes and the discount persists, the stock could fall to the analyst low target of $12.00? Actually, the analyst low target is $12.00, which is above the current price, so the downside is better framed by the 52-week low. A more severe scenario could see the stock test the $9-10 range, implying a 8-18% loss from current levels. The maximum drawdown of -28.29% over the past year shows the potential severity.
FAQ
The most severe risk is a dividend cut, given the 77.3% payout ratio and Q2 2026 dividends of $113.37 million exceeding operating cash flow of $84.15 million. Second, extreme leverage (debt-to-equity 5.65x) leaves little cushion if repo financing costs rise or haircuts increase. Third, book value erosion from spread widening could widen the discount to book. Fourth, share dilution from equity raises (shares outstanding nearly doubled YoY) dilutes per-share value. These risks are ranked by severity, with dividend sustainability being the most immediate threat.
Our 12-month forecast has three scenarios: bull case (25% probability) targets $13.75-$15.00 if spreads stabilize and the dividend is maintained; base case (50%) targets $12.00-$13.75 as the stock gradually recovers; bear case (25%) targets $10.36-$11.00 if a dividend cut or book value erosion occurs. The base case is most likely, assuming no dividend cut and stable repo financing. Key catalysts include Fed rate cuts, quarterly book value reports, and dividend announcements.
DX appears undervalued on a price-to-book basis, trading at 0.71x versus its historical range of 0.68x-0.94x and the sector's 0.8x-1.0x. The trailing PE of 5.63x and forward PE of 7.10x are low, but earnings are volatile and mark-driven. The 14.18% dividend yield is well above the sector's 9-11%, signaling market skepticism about sustainability. The discount implies the market expects book value erosion and dividend risk; if those fears prove overblown, the stock could re-rate toward book value.
DX is a high-risk, high-reward buy for income-focused investors. It offers a 14.18% dividend yield and trades at a 29% discount to book value (PB 0.71x), with analysts seeing 25.8% upside to their average target of $13.75. However, the stock is in a severe downtrend (-22.37% YTD) and the dividend's 77.3% payout ratio raises sustainability concerns. The biggest downside risk is a dividend cut, which could push the stock toward its 52-week low of $10.36. It may be a good buy for contrarian investors with a long horizon, but only after the price stabilizes or dividend coverage improves.
DX is better suited for long-term income-focused investors who can tolerate volatility and potential dividend cuts. Its beta of 0.965 and high leverage make it volatile, and the current downtrend suggests short-term trading is risky. The 14.18% yield is attractive for income, but the 77.3% payout ratio means the dividend is not secure. A minimum holding period of 2-3 years is recommended to ride out spread cycles and potential book value recovery. Short-term traders should wait for technical stabilization above $11.50-$12.00 before entering.